Intuitive Surgical Inc has a consensus price target of $408.04 based on the ratings of 28 analysts. The high is $520 issued by Truist Securities on July 19, 2024. The low is $278 issued by UBS on March 29, 2023. The 3 most-recent analyst ratings were released by Barclays, JP Morgan, and Morgan Stanley on July 23, 2024, July 19, 2024, and July 19, 2024, respectively. With an average price target of $493.33 between Barclays, JP Morgan, and Morgan Stanley, there's an implied 7.77% upside for Intuitive Surgical Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/23/2024 | Buy Now | 11.41% | Barclays | Matt Miksic | $490 → $510 | Maintains | Overweight | Get Alert |
07/19/2024 | Buy Now | 8.13% | JP Morgan | Sterling Auty | $475 → $495 | Maintains | Overweight | Get Alert |
07/19/2024 | Buy Now | 3.76% | Morgan Stanley | Cecilia Furlong | $460 → $475 | Maintains | Equal-Weight | Get Alert |
07/19/2024 | Buy Now | 13.59% | Truist Securities | Richard Newitter | $515 → $520 | Maintains | Buy | Get Alert |
07/19/2024 | Buy Now | 2.45% | BTIG | Ryan Zimmerman | $459 → $469 | Maintains | Buy | Get Alert |
07/19/2024 | Buy Now | -10.44% | Evercore ISI Group | Vijay Kumar | $425 → $410 | Maintains | In-Line | Get Alert |
07/19/2024 | Buy Now | 3.76% | Stifel | Rick Wise | $430 → $475 | Maintains | Buy | Get Alert |
07/19/2024 | Buy Now | 8.13% | Piper Sandler | Adam Maeder | $490 → $495 | Maintains | Overweight | Get Alert |
07/19/2024 | Buy Now | 9.88% | Baird | Mike Polark | $487 → $503 | Maintains | Outperform | Get Alert |
07/18/2024 | Buy Now | 7.04% | Barclays | Matt Miksic | $430 → $490 | Maintains | Overweight | Get Alert |
07/16/2024 | Buy Now | 12.5% | Truist Securities | Richard Newitter | $450 → $515 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 0.27% | BTIG | Ryan Zimmerman | $451 → $459 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 0.49% | Morgan Stanley | Cecilia Furlong | $375 → $460 | Maintains | Equal-Weight | Get Alert |
07/10/2024 | Buy Now | 11.85% | Citigroup | Joanne Wuensch | $462 → $512 | Maintains | Buy | Get Alert |
07/09/2024 | Buy Now | 7.04% | Piper Sandler | Adam Maeder | $435 → $490 | Maintains | Overweight | Get Alert |
07/02/2024 | Buy Now | -7.16% | Evercore ISI Group | Vijay Kumar | $385 → $425 | Maintains | In-Line | Get Alert |
05/30/2024 | Buy Now | 9.23% | Goldman Sachs | David Roman | → $500 | Initiates | → Buy | Get Alert |
04/19/2024 | Buy Now | -8.03% | BTIG | Ryan Zimmerman | $412 → $421 | Maintains | Buy | Get Alert |
04/19/2024 | Buy Now | -4.97% | Piper Sandler | Adam Maeder | $425 → $435 | Maintains | Overweight | Get Alert |
04/19/2024 | Buy Now | -18.08% | Jefferies | David Windley | $365 → $375 | Maintains | Hold | Get Alert |
04/19/2024 | Buy Now | -4.76% | Baird | Mike Polark | $440 → $436 | Maintains | Outperform | Get Alert |
04/08/2024 | Buy Now | -6.07% | Stifel | Rick Wise | $420 → $430 | Maintains | Buy | Get Alert |
04/03/2024 | Buy Now | 0.92% | Citigroup | Joanne Wuensch | $428 → $462 | Maintains | Buy | Get Alert |
03/15/2024 | Buy Now | -8.25% | Stifel | Rick Wise | → $420 | Reiterates | Buy → Buy | Get Alert |
01/25/2024 | Buy Now | -14.8% | Mizuho | Anthony Petrone | $350 → $390 | Maintains | Neutral | Get Alert |
01/25/2024 | Buy Now | -6.07% | Barclays | Matt Miksic | $385 → $430 | Maintains | Overweight | Get Alert |
01/25/2024 | Buy Now | -4.97% | Raymond James | Jayson Bedford | $372 → $435 | Maintains | Outperform | Get Alert |
01/24/2024 | Buy Now | -5.63% | RBC Capital | Shagun Singh | $400 → $432 | Maintains | Outperform | Get Alert |
01/24/2024 | Buy Now | -8.25% | Stifel | Rick Wise | $360 → $420 | Maintains | Buy | Get Alert |
01/24/2024 | Buy Now | -4.97% | Truist Securities | Richard Newitter | $390 → $435 | Maintains | Buy | Get Alert |
01/24/2024 | Buy Now | -7.16% | Piper Sandler | Adam Maeder | $325 → $425 | Maintains | Overweight | Get Alert |
01/19/2024 | Buy Now | -9.12% | Wells Fargo | Larry Biegelsen | $363 → $416 | Maintains | Overweight | Get Alert |
01/12/2024 | Buy Now | -12.62% | RBC Capital | Shagun Singh | $380 → $400 | Maintains | Outperform | Get Alert |
01/03/2024 | Buy Now | -18.74% | Raymond James | Jason Bednar | $310 → $372 | Maintains | Outperform | Get Alert |
12/22/2023 | Buy Now | -14.8% | Truist Securities | Richard Newitter | $375 → $390 | Maintains | Buy | Get Alert |
12/12/2023 | Buy Now | -18.08% | Truist Securities | Richard Newitter | $320 → $375 | Maintains | Buy | Get Alert |
12/04/2023 | Buy Now | -27.91% | Morgan Stanley | Cecilia Furlong | $300 → $330 | Maintains | Equal-Weight | Get Alert |
11/17/2023 | Buy Now | -23.54% | Stifel | Rick Wise | $315 → $350 | Maintains | Buy | Get Alert |
11/17/2023 | Buy Now | -30.53% | HSBC | Helen Fang | → $318 | Initiates | → Buy | Get Alert |
10/23/2023 | Buy Now | -34.46% | Morgan Stanley | Cecilia Furlong | $330 → $300 | Maintains | Equal-Weight | Get Alert |
10/20/2023 | Buy Now | -29% | Piper Sandler | Richard Repetto | $385 → $325 | Maintains | Overweight | Get Alert |
10/20/2023 | Buy Now | -22.45% | RBC Capital | Shagun Singh | → $355 | Reiterates | Outperform → Outperform | Get Alert |
10/20/2023 | Buy Now | -14.8% | Citigroup | Joanne Wuensch | $400 → $390 | Maintains | Buy | Get Alert |
10/20/2023 | Buy Now | -20.7% | Wells Fargo | Larry Biegelsen | $386 → $363 | Maintains | Overweight | Get Alert |
10/20/2023 | Buy Now | -32.28% | Raymond James | Jason Bednar | $368 → $310 | Maintains | Outperform | Get Alert |
10/16/2023 | Buy Now | -25.29% | Leerink Partners | Mike Kratky | → $342 | Initiates | → Outperform | Get Alert |
08/17/2023 | Buy Now | -21.36% | RBC Capital | Shagun Singh | → $360 | Reiterates | Outperform → Outperform | Get Alert |
07/24/2023 | Buy Now | -27.91% | Morgan Stanley | Cecilia Furlong | $310 → $330 | Maintains | Equal-Weight | Get Alert |
07/24/2023 | Buy Now | -15.9% | Barclays | Matt Miksic | $314 → $385 | Maintains | Overweight | Get Alert |
07/24/2023 | Buy Now | -19.61% | Raymond James | Jason Bednar | $323 → $368 | Maintains | Outperform | Get Alert |
07/21/2023 | Buy Now | -20.27% | JP Morgan | Robbie Marcus | $335 → $365 | Maintains | Overweight | Get Alert |
07/21/2023 | Buy Now | -15.9% | Piper Sandler | Richard Repetto | $315 → $385 | Maintains | Overweight | Get Alert |
07/21/2023 | Buy Now | -21.36% | RBC Capital | Shagun Singh | $355 → $360 | Maintains | Outperform | Get Alert |
07/21/2023 | Buy Now | -15.68% | Wells Fargo | Larry Biegelsen | $310 → $386 | Maintains | Overweight | Get Alert |
07/19/2023 | Buy Now | -12.62% | Truist Securities | Richard Newitter | $347 → $400 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | -17.64% | Baird | Mike Polark | → $377 | Initiates | Outperform → Outperform | Get Alert |
07/12/2023 | Buy Now | -22.45% | RBC Capital | Shagun Singh | $309 → $355 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | -12.62% | Citigroup | Joanne Wuensch | $317 → $400 | Maintains | Buy | Get Alert |
06/05/2023 | Buy Now | -28.79% | BTIG | Ryan Zimmerman | $313 → $326 | Maintains | Buy | Get Alert |
05/31/2023 | Buy Now | -32.28% | Morgan Stanley | Cecilia Furlong | $285 → $310 | Maintains | Equal-Weight | Get Alert |
05/31/2023 | Buy Now | -20.27% | Bernstein | Lee Hambright | $350 → $365 | Maintains | Outperform | Get Alert |
05/18/2023 | Buy Now | -24.2% | Truist Securities | Richard Newitter | $325 → $347 | Maintains | Buy | Get Alert |
04/24/2023 | Buy Now | -32.5% | RBC Capital | Shagun Singh | → $309 | Reiterates | → Outperform | Get Alert |
04/20/2023 | Buy Now | -23.54% | Bernstein | Lee Hambright | $325 → $350 | Maintains | Outperform | Get Alert |
04/20/2023 | Buy Now | -31.41% | Barclays | Matt Miksic | $298 → $314 | Maintains | Overweight | Get Alert |
04/19/2023 | Buy Now | -31.19% | Stifel | Matthew Sheerin | $285 → $315 | Maintains | Buy | Get Alert |
04/19/2023 | Buy Now | -36.65% | Deutsche Bank | Imron Zafar | $245 → $290 | Maintains | Hold | Get Alert |
04/19/2023 | Buy Now | -31.19% | Piper Sandler | Richard Repetto | $265 → $315 | Maintains | Overweight | Get Alert |
04/19/2023 | Buy Now | -31.63% | BTIG | Ryan Zimmerman | $284 → $313 | Maintains | Buy | Get Alert |
04/19/2023 | Buy Now | -41.02% | Evercore ISI Group | Vijay Kumar | $240 → $270 | Maintains | In-Line | Get Alert |
04/19/2023 | Buy Now | -26.82% | JP Morgan | Robbie Marcus | $250 → $335 | Maintains | Overweight | Get Alert |
04/19/2023 | Buy Now | -32.5% | RBC Capital | Shagun Singh | $305 → $309 | Maintains | Outperform | Get Alert |
04/19/2023 | Buy Now | -37.74% | Morgan Stanley | Cecilia Furlong | $265 → $285 | Maintains | Equal-Weight | Get Alert |
04/19/2023 | Buy Now | -29% | Truist Securities | Richard Newitter | $300 → $325 | Maintains | Buy | Get Alert |
04/19/2023 | Buy Now | -31.19% | B of A Securities | Travis Steed | $300 → $315 | Maintains | Buy | Get Alert |
04/19/2023 | Buy Now | -34.46% | Mizuho | Anthony Petrone | $250 → $300 | Maintains | Neutral | Get Alert |
04/19/2023 | Buy Now | -32.28% | Wells Fargo | Larry Biegelsen | $289 → $310 | Maintains | Overweight | Get Alert |
04/19/2023 | Buy Now | -29.44% | Raymond James | Jason Bednar | $270 → $323 | Maintains | Outperform | Get Alert |
04/19/2023 | Buy Now | -30.75% | Citigroup | Joanne Wuensch | $305 → $317 | Maintains | Buy | Get Alert |
04/18/2023 | Buy Now | -45.39% | Mizuho | Anthony Petrone | $240 → $250 | Maintains | Neutral | Get Alert |
04/17/2023 | Buy Now | -37.96% | BTIG | Ryan Zimmerman | $279 → $284 | Maintains | Buy | Get Alert |
04/04/2023 | Buy Now | -47.57% | Evercore ISI Group | Vijay Kumar | $215 → $240 | Maintains | In-Line | Get Alert |
03/29/2023 | Buy Now | -39.27% | UBS | Danielle Antalffy | → $278 | Initiates | → Neutral | Get Alert |
03/23/2023 | Buy Now | — | William Blair | Brandon Vazquez | — | Initiates | → Outperform | Get Alert |
01/26/2023 | Buy Now | -41.02% | Raymond James | Jayson Bedford | $255 → $270 | Maintains | Outperform | Get Alert |
01/25/2023 | Buy Now | -47.57% | Mizuho | Anthony Petrone | $245 → $240 | Maintains | Neutral | Get Alert |
01/25/2023 | Buy Now | -33.37% | Citigroup | Joanne Wuensch | $318 → $305 | Maintains | Buy | Get Alert |
01/25/2023 | Buy Now | -39.05% | BTIG | Ryan Zimmerman | $316 → $279 | Maintains | Buy | Get Alert |
01/25/2023 | Buy Now | -42.11% | Morgan Stanley | Cecilia Furlong | $290 → $265 | Maintains | Equal-Weight | Get Alert |
01/25/2023 | Buy Now | -34.46% | Truist Securities | Richard Newitter | $310 → $300 | Maintains | Buy | Get Alert |
01/25/2023 | Buy Now | -36.87% | Wells Fargo | Larry Biegelsen | $305 → $289 | Maintains | Overweight | Get Alert |
01/24/2023 | Buy Now | -46.48% | Mizuho | Anthony Petrone | $215 → $245 | Maintains | Neutral | Get Alert |
01/06/2023 | Buy Now | -36.65% | Morgan Stanley | Cecilia Furlong | $235 → $290 | Maintains | Equal-Weight | Get Alert |
12/22/2022 | Buy Now | -30.1% | Argus Research | David Toung | $265 → $320 | Maintains | Buy | Get Alert |
12/20/2022 | Buy Now | -32.28% | Truist Securities | Richard Newitter | $300 → $310 | Maintains | Buy | Get Alert |
12/12/2022 | Buy Now | -33.37% | Wells Fargo | Larry Biegelsen | $262 → $305 | Maintains | Overweight | Get Alert |
12/05/2022 | Buy Now | -30.97% | BTIG | Ryan Zimmerman | $247 → $316 | Maintains | Buy | Get Alert |
11/18/2022 | Buy Now | -38.83% | JP Morgan | Robbie Marcus | $250 → $280 | Maintains | Overweight | Get Alert |
10/20/2022 | Buy Now | -49.76% | Deutsche Bank | Imron Zafar | $205 → $230 | Maintains | Hold | Get Alert |
10/19/2022 | Buy Now | -48.66% | Morgan Stanley | Cecilia Furlong | $215 → $235 | Maintains | Equal-Weight | Get Alert |
The latest price target for Intuitive Surgical (NASDAQ:ISRG) was reported by Barclays on July 23, 2024. The analyst firm set a price target for $510.00 expecting ISRG to rise to within 12 months (a possible 11.41% upside). 50 analyst firms have reported ratings in the last year.
The latest analyst rating for Intuitive Surgical (NASDAQ:ISRG) was provided by Barclays, and Intuitive Surgical maintained their overweight rating.
There is no last upgrade for Intuitive Surgical
There is no last downgrade for Intuitive Surgical.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Intuitive Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Intuitive Surgical was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
While ratings are subjective and will change, the latest Intuitive Surgical (ISRG) rating was a maintained with a price target of $490.00 to $510.00. The current price Intuitive Surgical (ISRG) is trading at is $457.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.